FDA OKs First Gene Therapy for Beta-Thalassemia

(MedPage Today) -- Betibeglogene autotemcel (beti-cel; Zynteglo) won FDA approval Wednesday as the first gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell (RBC) transfusions...